Stay updated on Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Padova, Italy, 35128 has been added to the locations and Padua, Italy, 35128 has been removed.
    Difference
    0.0%
    Check dated 2026-04-05T17:13:18.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision notes show the page updated to version 3.5.0 (2026-03-16) with related changes, and the earlier version 3.4.3 (2026-02-12) removed.
    Difference
    0.1%
    Check dated 2026-03-22T08:40:46.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The study record metadata has been updated with a new revision (v3.4.3) and added/adjusted dates (e.g., 2027-06-30 completion, 2026-02-12 QC date), with some older metadata dates removed.
    Difference
    0.1%
    Check dated 2026-03-15T04:07:18.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision v3.4.2 was added and revision v3.4.1 was removed.
    Difference
    0.0%
    Check dated 2026-02-14T12:39:30.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Posted results data for the PALOMA-3 study, including Ctrough and AUC Day 1-15 PK endpoints for Cycle 2 Day 1 and Cycle 4 Day 1, with regional notes and timing details. Deleted several earlier results metrics definitions that were previously shown.
    Difference
    2%
    Check dated 2026-02-07T07:49:07.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The changes update and standardize metadata display (glossary toggle, last update fields, FEAR Act labeling, and revision version) with some capitalization adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-24T03:08:07.000Z thumbnail image

Stay in the know with updates to Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.